14. Как не умереть от болезни Паркинсона

14. Как не умереть от болезни Паркинсона

^{‹‹1››.} Jafari S, Etminan M, Aminzadeh F, Samii A. Head injury and risk of Parkinson disease: a systematic review and meta-analysis. Mov Disord. 2013;28(9):1222–9.

^{‹‹2››.} National Cancer Institute. President’s Cancer Panel. Reducing environmental cancer risk: what we can do now. http://deainfo.nci.nih.gov/advisory/pcp/annualReports/pcp08-09rpt/PCP_Report_08-09_508.pdf. April 2010. Accessed March 12, 2015.

^{‹‹3››.} Zeliger HI. Exposure to lipophilic chemicals as a cause of neurological impairments, neurodevelopmental disorders and neurodegenerative diseases. Interdiscip Toxicol. 2013;6(3): 103–10.

^{‹‹4››.} Woodruff TJ, Zota AR, Schwartz JM. Environmental chemicals in pregnant women in the United States: NHANES 2003–2004. Environ Health Perspect. 2011;119(6):878–85.

^{‹‹5››.} Woodruff TJ, Zota AR, Schwartz JM. Environmental chemicals in pregnant women in the United States: NHANES 2003–2004. Environ Health Perspect. 2011;119(6):878–85.

^{‹‹6››.} Mariscal-Arcas M, Lopez-Martinez C, Granada A, Olea N, Lorenzo-Tovar ML, Olea-Serrano F. Organochlorine pesticides in umbilical cord blood serum of women from Southern Spain and adherence to the Mediterranean diet. Food Chem Toxicol. 2010;48(5):1311–5.

^{‹‹7››.} Bjermo H, Darnerud PO, Lignell S, et al. Fish intake and breastfeeding time are associated with serum concentrations of organochlorines in a Swedish population. Environ Int. 2013;51:88–96.

^{‹‹8››.} Glynn A, Larsdotter M, Aune M, Darnerud PO, Bjerselius R, Bergman A. Changes in serum concentrations of polychlorinated biphenyls (PCBs), hydroxylated PCB metabolites and pentachlorophenol during pregnancy. Chemosphere. 2011;83(2):144–51.

^{‹‹9››.} Soechitram SD, Athanasiadou M, Hovander L, Bergman A, Sauer PJ. Fetal exposure to PCBs and their hydroxylated metabolites in a Dutch cohort. Environ Health Perspect. 2004;112(11): 1208–12.

^{‹‹10››.} Ulaszewska MM, Zuccato E, Davoli E. PCDD/Fs and dioxin-like PCBs in human milk and estimation of infants’ daily intake: a review. Chemosphere. 2011;83(6):774–82.

^{‹‹11››.} Gallo MV, Schell LM, Decaprio AP, Jacobs A. Levels of persistent organic pollutant and their predictors among young adults. Chemosphere. 2011;83(10):1374–82.

^{‹‹12››.} Ulaszewska MM, Zuccato E, Davoli E. PCDD/Fs and dioxin-like PCBs in human milk and estimation of infants’ daily intake: a review. Chemosphere. 2011;83(6):774–82.

^{‹‹13››.} Aliyu MH, Alio AP, Salihu HM. To breastfeed or not to breastfeed: a review of the impact of lactational exposure to polychlorinated biphenyls (PCBs) on infants. J Environ Health. 2010; 73(3): 8–14.

^{‹‹14››.} Vogt R, Bennett D, Cassady D, Frost J, Ritz B, Hertz-Picciotto I. Cancer and non-cancer health effects from food contaminant exposures for children and adults in California: a risk assessment. Environ Health. 2012;11:83.

^{‹‹15››.} Vogt R, Bennett D, Cassady D, Frost J, Ritz B, Hertz-Picciotto I. Cancer and non-cancer health effects from food contaminant exposures for children and adults in California: a risk assessment. Environ Health. 2012;11:Table S3. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551655/bin/1476-069X-11-83-S3.doc. Accessed March 28, 2015.

^{‹‹16››.} Vogt R, Bennett D, Cassady D, Frost J, Ritz B, Hertz-Picciotto I. Cancer and non-cancer health effects from food contaminant exposures for children and adults in California: a risk assessment. Environ Health. 2012;11:83.

^{‹‹17››.} Dorea JG, Bezerra VL, Fajon V, Horvat M. Speciation of methyl-and ethyl-mercury in hair of breastfed infants acutely exposed to thimerosal-containing vaccines. Clin Chim Acta. 2011; 412(17–18): 1563–6.

^{‹‹18››.} Zeilmaker MJ, Hoekstra J, van Eijkeren JC, et al. Fish consumption during child bearing age: a quantitative risk-benefi t analysis on neurodevelopment. Food Chem Toxicol. 2013;54: 30–4.

^{‹‹19››.} Fromberg A, Granby K, H?jg?rd A, Fagt S, Larsen JC. Estimation of dietary intake of PCB and organochlorine pesticides for children and adults. Food Chem. 2011;125:1179–87.

^{‹‹20››.} European Food Safety Authority. Results of the monitoring of non dioxin-like PCBs in food and feed. EFSA Journal. 2010;8(7):1701.

^{‹‹21››.} Fromberg A, Granby K, H?jg?rd A, Fagt S, Larsen JC. Estimation of dietary intake of PCB and organochlorine pesticides for children and adults. Food Chem. 2011;125:1179–87.

^{‹‹22››.} Zhang T, Sun HW, Wu Q, Zhang XZ, Yun SH, Kannan K. Perfl uorochemicals in meat, eggs and indoor dust in China: assessment of sources and pathways of human exposure to perfl uorochemicals. Environ Sci Technol. 2010;44(9):3572–9.

^{‹‹23››.} Schecter A, Cramer P, Boggess K, et al. Intake of dioxins and related compounds from food in the U.S. population. J Toxicol Environ Health Part A. 2001;63(1):1–18.

^{‹‹24››.} Aune D, De Stefani E, Ronco AL, et al. Egg consumption and the risk of cancer: a multisite case-control study in Uruguay. Asian Pac J Cancer Prev. 2009;10(5):869–76.

^{‹‹25››.} Yaginuma-Sakurai K, Murata K, Iwai-Shimada M, et al. Hair-to-blood ratio and biological halflife of mercury: experimental study of methylmercury exposure through fish consumption in humans. J Toxicol Sci. 2012;37(1):123–30.

^{‹‹26››.} Wimmerov? S, Lancz K, Tih?nyi J, et al. Half-lives of serum PCB congener concentrations in environmentally exposed early adolescents. Chemosphere. 2011;82(5):687–91.

^{‹‹27››.} Hageman KJ, Hafner WD, Campbell DH, Jaffe DA, Landers DH, Simonich SL. Variability in pesticide deposition and source contributions to snowpack in Western U.S. national parks. Environ Sci Technol. 2010;44(12):4452–8.

^{‹‹28››.} Schecter A, Startin J, Wright C, et al. Congener-specific levels of dioxins and dibenzofurans in U.S. food and estimated daily dioxin toxic equivalent intake. Environ Health Perspect. 1994; 102(11):962–6.

^{‹‹29››.} Fiedler H, Cooper KR, Bergek S, Hjelt M, Rappe C. Polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans (PCDD/PCDF) in food samples collected in southern Mississippi, USA. Chemosphere. 1997;34(5–7):1411–9.

^{‹‹30››.} Rappe C, Bergek S, Fiedler H, Cooper KR. PCDD and PCDF contamination in catfish feed from Arkansas, USA. Chemosphere. 1998;36(13):2705–20.

^{‹‹31››.} Ferrario JB, Byrne CJ, Cleverly DH. 2,3,7,8-Dibenzo-p-dioxins in mined clay products from the United States: evidence for possible natural origin. Environ Sci Technol. 2000;34(21): 4524–32.

^{‹‹32››.} US Department of Commerce. Broiler, turkey, and egg production: 1980 to 1999, No. 1143, p. 684. In Statistical Abstract of the United States, 2000. Washington, D.C.: Government Printing Office, 2000.

^{‹‹33››.} Hayward DG, Nortrup D, Gardner A, Clower M. Elevated TCDD in chicken eggs and farmraised catfish fed a diet with ball clay from a Southern United States mine. Environ Res. 1999; 81(3):248–56.

^{‹‹34››.} Hayward DG, Nortrup D, Gardner A, Clower M. Elevated TCDD in chicken eggs and farmraised catfish fed a diet with ball clay from a Southern United States mine. Environ Res. 1999; 81(3):248–56.

^{‹‹35››.} US Food and Drug Administration. Letter from Linda Tollefson to Producers or Users of Clay Products in Animal Feeds. https://web.archive.org/web/20081107120600/ http://www.fda.gov/cvm/Documents/ballclay.pdf. October 7, 1997. Accessed March 12, 2015.

^{‹‹36››.} Hanson T, Sites D. 2012 US catfish database. Fisheries and Allied Aquacultures Department Series No. 6. http://aurora.auburn.edu/repo/bitstream/handle/11200/44174/2012%2 °Catfish%20Database.pdf?sequence=1. March 2013. Accessed March 26, 2015.

^{‹‹37››.} Huwe JK, Archer JC. Dioxin congener patterns in commercial catfish from the United States and the indication of mineral clays as the potential source. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2013;30(2):331–8.

^{‹‹38››.} Rappe C, Bergek S, Fiedler H, Cooper KR. PCDD and PCDF contamination in catfish feed from Arkansas, USA. Chemosphere. 1998;36(13):2705–20.

^{‹‹39››.} Yaktine AL, Harrison GG, Lawrence RS. Reducing exposure to dioxins and related compounds through foods in the next generation. Nutr Rev. 2006;64(9):403–9.

^{‹‹40››.} Schecter A, Startin J, Wright C, et al. Congener-specific levels of dioxins and dibenzofurans in U.S. food and estimated daily dioxin toxic equivalent intake. Environ Health Perspect. 1994; 102(11):962–6.

^{‹‹41››.} US Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.

^{‹‹42››.} Lee PN. 1979 Surgeon General’s Report. http://legacy.library.ucsf.edu/tid/zkl36b00/pdf?search=%221979%20surgeon%20general%20s%20report%20lee%22. September 2, 1979. Accessed March 12, 2015.

^{‹‹43››.} Lee PN. 1979 Surgeon General’s Report. http://legacy.library.ucsf.edu/tid/zkl36b00/pdf?search=%221979%20surgeon%20general%20s%20report%20lee%22. September 2, 1979. Accessed March 12, 2015.

^{‹‹44››.} Hearings before the Subcommittee on Public Buildings and Grounds of the Committee on Public Works and Transportation to Prohibit Smoking in Federal Buildings. http://legacy.library.ucsf.edu/tid/fzt08h00/pdf?search=%22to%20prohibit%20smoking%20in%20federal%20buildings%20hearings%20jd%20047710%22. March 11; April 22, 1993. Accessed March 12, 2015.

^{‹‹45››.} Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol. 2012;72(6):893–901.

^{‹‹46››.} Morens DM, Grandinetti A, Davis JW, Ross GW, White LR, Reed D. Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease. Am J Epidemiol. 1996;144(4):400–4.

^{‹‹47››.} Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol. 2012;72(6):893–901.

^{‹‹48››.} Allam MF, Campbell MJ, Del Castillo AS, Fern?ndez-Crehuet Navajas R. Parkinson’s disease protects against smoking? Behav Neurol. 2004;15(3–4):65–71.

^{‹‹49››.} Tanner CM, Goldman SM, Aston DA, et al. Smoking and Parkinson’s disease in twins. Neurology. 2002;58(4):581–8.

^{‹‹50››.} O’Reilly EJ, Chen H, Gardener H, Gao X, Schwarzschild MA, Ascherio A. Smoking and Parkinson’s disease: using parental smoking as a proxy to explore causality. Am J Epidemiol. 2009;169(6): 678–82.

^{‹‹51››.} US Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.

^{‹‹52››.} Wolf PA, D’Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA. 1988;259(7):1025–9.

^{‹‹53››.} Quik M, Perez XA, Bordia T. Nicotine as a potential neuroprotective agent for Parkinson’s disease. Mov Disord. 2012;27(8):947–57.

^{‹‹54››.} Siegmund B, Leitner E, Pfannhauser W. Determination of the nicotine content of various edible nightshades (Solanaceae) and their products and estimation of the associated dietary nicotine intake. J Agric Food Chem. 1999;47(8):3113–20.

^{‹‹55››.} Brody AL, Mandelkern MA, London ED, et al. Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch Gen Psychiatry. 2006;63(8):907–15.

^{‹‹56››.} Searles Nielsen S, Gallagher LG, Lundin JI, et al. Environmental tobacco smoke and Parkinson’s disease. Mov Disord. 2012;27(2):293–6.

^{‹‹57››.} Siegmund B, Leitner E, Pfannhauser W. Determination of the nicotine content of various edible nightshades (Solanaceae) and their products and estimation of the associated dietary nicotine intake. J Agric Food Chem. 1999;47(8):3113–20.

^{‹‹58››.} Nielsen SS, Franklin GM, Longstreth WT, Swanson PD, Checkoway H. Nicotine from edible Solanaceae and risk of Parkinson disease. Ann Neurol. 2013;74(3):472–7.

^{‹‹59››.} Nielsen SS, Franklin GM, Longstreth WT, Swanson PD, Checkoway H. Nicotine from edible Solanaceae and risk of Parkinson disease. Ann Neurol. 2013;74(3):472–7.

^{‹‹60››.} Richardson JR, Shalat SL, Buckley B, et al. Elevated serum pesticide levels and risk of Parkinson disease. Arch Neurol. 2009;66(7):870–5.

^{‹‹61››.} Corrigan FM, Wienburg CL, Shore RF, Daniel SE, Mann D. Organochlorine insecticides in substantia nigra in Parkinson’s disease. J Toxicol Environ Health Part A. 2000;59(4):229–34.

^{‹‹62››.} Hatcher-Martin JM, Gearing M, Steenland K, Levey AI, Miller GW, Pennell KD. Association between polychlorinated biphenyls and Parkinson’s disease neuropathology. Neurotoxicology. 2012; 33(5):1298–304.

^{‹‹63››.} Kanthasamy AG, Kitazawa M, Kanthasamy A, Anantharam V. Dieldrin-induced neurotoxicity: relevance to Parkinson’s disease pathogenesis. Neurotoxicology. 2005;26(4):701–19.

^{‹‹64››.} Arguin H, Sanchez M, Bray GA, et al. Impact of adopting a vegan diet or an olestra supplementation on plasma organochlorine concentrations: results from two pilot studies. Br J Nutr. 2010; 103(10):1433–41.

^{‹‹65››.} Jiang W, Ju C, Jiang H, Zhang D. Dairy foods intake and risk of Parkinson’s disease: a dose-response meta-analysis of prospective cohort studies. Eur J Epidemiol. 2014;29(9):613–9.

^{‹‹66››.} Park M, Ross GW, Petrovitch H, et al. Consumption of milk and calcium in midlife and the future risk of Parkinson disease. Neurology. 2005;64(6):1047–51.

^{‹‹67››.} Kotake Y, Yoshida M, Ogawa M, Tasaki Y, Hirobe M, Ohta S. Chronic administration of 1-benzyl- 1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate. Neurosci Lett. 1996;217(1):69–71.

^{‹‹68››.} Niwa T, Yoshizumi H, Takeda N, Tatematsu A, Matsuura S, Nagatsu T. Detection of tetrahy- droisoquinoline, a parkinsonism-related compound, in parkinsonian brains and foods by gas chromatography- mass spectrometry. Advances in Behavioral Biology. 1990;38A:313–6.

^{‹‹69››.} Niwa T, Yoshizumi H, Tatematsu A, Matsuura S, Nagatsu T. Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods. J Chromatogr. 1989;493(2):347–52.

^{‹‹70››.} Niwa T, Takeda N, Kaneda N, Hashizume Y, Nagatsu T. Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains. Biochem Biophys Res Commun. 1987;144(2):1084–9.

^{‹‹71››.} U?amek-Kozio? M, Bogucka-Kocka A, Kocki J, Pluta R. Good and bad sides of diet in Parkinson’s disease. Nutrition. 2013;29(2):474–5.

^{‹‹72››.} U?amek-Kozio? M, Bogucka-Kocka A, Kocki J, Pluta R. Good and bad sides of diet in Parkinson’s disease. Nutrition. 2013;29(2):474–5.

^{‹‹73››.} Kistner A, Krack P. Parkinson’s disease: no milk today? Front Neurol. 2014;5:172.

^{‹‹74››.} Chen H, Zhang SM, Hernn MA, Willett WC, Ascherio A. Diet and Parkinson’s disease: a potential role of dairy products in men. Ann Neurol. 2002;52(6):793–801.

^{‹‹75››.} Jiang W, Ju C, Jiang H, Zhang D. Dairy foods intake and risk of Parkinson’s disease: a dose-response meta-analysis of prospective cohort studies. Eur J Epidemiol. 2014;29(9):613–9.

^{‹‹76››.} Micha?lsson K, Wolk A, Langenski?ld S, et al. Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ. 2014;349:g6015.

^{‹‹77››.} Ridel KR, Leslie ND, Gilbert DL. An updated review of the long-term neurological effects of galactosemia. Pediatr Neurol. 2005;33(3):153–61.

^{‹‹78››.} Marder K, Gu Y, Eberly S, et al. Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease. JAMA Neurol. 2013;70(11):1382–8.

^{‹‹79››.} Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA. 1981;78(11):6858–62.

^{‹‹80››.} Duan W, Ladenheim B, Cutler RG, Kruman II, Cadet JL, Mattson MP. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson’s disease. J Neurochem. 2002;80(1):101–10.

^{‹‹81››.} Auinger P, Kieburtz K, McDermott MP. The relationship between uric acid levels and Huntington’s disease progression. Mov Disord. 2010;25(2):224–8.

^{‹‹82››.} Schwarzschild MA, Schwid SR, Marek K, et al. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol. 2008;65(6):716–23.

^{‹‹83››.} Shen C, Guo Y, Luo W, Lin C, Ding M. Serum urate and the risk of Parkinson’s disease: results from a meta-analysis. Can J Neurol Sci. 2013;40(1):73–9.

^{‹‹84››.} Fang P, Li X, Luo JJ, Wang H, Yang X. A double-edged sword: uric acid and neurological disorders. Brain Disord Ther. 2013;2(2):109.

^{‹‹85››.} Kutzing MK, Firestein BL. Altered uric acid levels and disease states. J Pharmacol Exp Ther. 2008;324(1):1–7.

^{‹‹86››.} Schmidt JA, Crowe FL, Appleby PN, Key TJ, Travis RC. Serum uric acid concentrations in meat eaters, fish eaters, vegetarians and vegans: a cross-sectional analysis in the EPIC-Oxford cohort. PLoS ONE. 2013;8(2):e56339.

^{‹‹87››.} Kuo CF, See LC, Yu KH, Chou IJ, Chiou MJ, Luo SF. Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology (Oxford). 2013;52(1): 127–34.

^{‹‹88››.} Arguin H, S?nchez M, Bray GA, et al. Impact of adopting a vegan diet or an olestra supplementation on plasma organochlorine concentrations: results from two pilot studies. Br J Nutr. 2010;103(10):1433–41.

^{‹‹89››.} Siddiqui MK, Saxena MC, Krishna Murti CR. Storage of DDT and BHC in adipose tissue of Indian males. Int J Environ Anal Chem. 1981;10(3–4):197–204.

^{‹‹90››.} Nor?n K. Levels of organochlorine contaminants in human milk in relation to the dietary habits of the mothers. Acta Paediatr Scand. 1983;72(6):811–6.

^{‹‹91››.} Schecter A, Papke O. Comparison of blood dioxin, dibenzofuran and coplanar PCB levels in strict vegetarians (vegans) and the general United States population. Org Comps. 1998;38: 179–82.

^{‹‹92››.} Schecter A, Harris TR, P?pke O, Tunga KC, Musumba A. Polybrominated diphenyl ether (PBDE) levels in the blood of pure vegetarians (vegans). Tox Env Chem. 2006;88(1):107–12.

^{‹‹93››.} Eskenazi B, Chevrier J, Rauch SA, et al. In utero and childhood polybrominated diphenyl ether (PBDE) exposures and neurodevelopment in the CHAMACOS study. Environ Health Perspect. 2013;121(2):257–62.

^{‹‹94››.} Schecter A, P?pke O, Harris TR, et al. Polybrominated diphenyl ether (PBDE) levels in an expanded market basket survey of U.S. food and estimated PBDE dietary intake by age and sex. Environ Health Perspect. 2006;114(10):1515–20.

^{‹‹95››.} Fraser AJ, Webster TF, McClean MD. Diet contributes significantly to the body burden of PBDEs in the general U.S. population. Environ Health Perspect. 2009;117(10):1520–5.

^{‹‹96››.} Schecter A, Harris TR, Papke O, Tunga KC, Musumba A. Polybrominated diphenyl ether (PBDE) levels in the blood of pure vegetarians (vegans). Tox Env Chem. 2006;88(1):107–12.

^{‹‹97››.} Huwe JK, West M. Polybrominated diphenyl ethers in U.S. meat and poultry from two statistically designed surveys showing trends and levels from 2002 to 2008. J Agric Food Chem. 2011; 59(10):5428–34.

^{‹‹98››.} Dickman MD, Leung CK, Leong MK. Hong Kong male subfertility links to mercury in human hair and fish. Sci Total Environ. 1998;214:165–74.

^{‹‹99››.} Srikumar TS, Johansson GK, Ockerman PA, Gustafsson JA, Akesson B. Trace element status in healthy subjects switching from a mixed to a lactovegetarian diet for 12 mo. Am J Clin Nutr. 1992; 55(4):885–90.

^{‹‹100››.} Wimmerov? S, Lancz K, Tih?nyi J, et al. Half-lives of serum PCB congener concentrations in environmentally exposed early adolescents. Chemosphere. 2011;82(5):687–91.

^{‹‹101››.} Parkinson J. An Essay on the Shaking Palsy. London: Whittingham and Rowland for Sherwood, Neely and Jones, 1817:7.

^{‹‹102››.} Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson’s disease. Neurology. 2001;57(3):456–62.

^{‹‹103››.} Ueki A, Otsuka M. Life style risks of Parkinson’s disease: association between decreased water intake and constipation. J Neurol. 2004;251 Suppl 7:vII18–23.

^{‹‹104››.} Gao X, Chen H, Schwarzschild MA, Ascherio A. A prospective study of bowel movement frequency and risk of Parkinson’s disease. Am J Epidemiol. 2011;174(5):546–51.

^{‹‹105››.} Kamel F. Epidemiology. Paths from pesticides to Parkinson’s. Science. 2013;341(6147): 722–3.

^{‹‹106››.} Barnhill LM, Bronstein JM. Pesticides and Parkinson’s disease: is it in your genes? Neurodegener Dis Manag. 2014;4(3):197–200.

^{‹‹107››.} Wang A, Cockburn M, Ly TT, Bronstein JM, Ritz B. The association between ambient exposure to organophosphates and Parkinson’s disease risk. Occup Environ Med. 2014;71(4): 275–81.

^{‹‹108››.} Narayan S, Liew Z, Paul K, et al. House hold organophosphorus pesticide use and Parkinson’s disease. Int J Epidemiol. 2013;42(5):1476–85.

^{‹‹109››.} Liu X, Ma T, Qu B, Ji Y, Liu Z. Pesticide-induced gene mutations and Parkinson disease risk: a meta- analysis. Genet Test Mol Biomarkers. 2013;17(11):826–32.

^{‹‹110››.} Lee SJ, Lim HS, Masliah E, Lee HJ. Protein aggregate spreading in neurodegenerative diseases: problems and perspectives. Neurosci Res. 2011;70(4):339–48.

^{‹‹111››.} Chorfa A, Lazizzera C, Betemps D, et al. A variety of pesticides trigger in vitro ?-synuclein accumulation, a key event in Parkinson’s disease. Arch Toxicol. 2014.

^{‹‹112››.} Dunnett SB, Bjorklund SBA. Prospects for new restorative and neuroprotective treatments in Parkinson’s disease. Nature. 1999;399(6738 Suppl):A32–9.

^{‹‹113››.} Campdelacreu J. Parkinson disease and Alzheimer disease: environmental risk factors. Neurologia. 2014;29(9):541–9.

^{‹‹114››.} Meng X, Munishkina LA, Fink AL, Uversky VN. Effects of various flavonoids on the ?-synuclein fibrillation process. Parkinson’s Dis. 2010;2010:650794.

^{‹‹115››.} Strathearn KE, Yousef GG, Grace MH, Roy SA, et al. Neuroprotective effects of anthocyaninand proanthocyanidin-rich extracts in cellular models of Parkinson’s disease. Brain Res. 2014; 1555:60–77.

^{‹‹116››.} Golbe LI, Farrell TM, Davis PH. Case-control study of early life dietary factors in Parkinson’s disease. Arch Neurol. 1988;45(12):1350–3.

^{‹‹117››.} Gao X, Cassidy A, Schwarzschild MA, Rimm EB, Ascherio A. Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurol. 2012;78(15):1138–45.

^{‹‹118››.} Kukull WA. An apple a day to prevent Parkinson disease: reduction of risk by flavonoids. Neurol. 2012;78(15):1112–3.

^{‹‹119››.} Gao X, Cassidy A, Schwarzschild MA, Rimm EB, Ascherio A. Habitual intake of dietary flavonoids and risk of Parkinson disease. Neurology. 2012;78(15):1138–45.

^{‹‹120››.} Serafini M, Testa MF, Villain D, et al. Antioxidant activity of blueberry fruit is impaired by association with milk. Free Radic Biol Med. 2009;46(6):769–74.

^{‹‹121››.} Jekanowski M. Survey says: a snapshot of rendering. Render Magazine. 2011;April:58–61.

^{‹‹122››.} Schepens PJ, Covaci A, Jorens PG, Hens L, Scharp? S, van Larebeke N. Surprising findings following a Belgian food contamination with polychlorobiphenyls and dioxins. Environ Health Perspect. 2001;109(2):101–3.

^{‹‹123››.} D?rea JG. Vegetarian diets and exposure to organochlorine pollutants, lead, and mercury. Am J Clin Nutr. 2004;80(1):237–8.

^{‹‹124››.} D?rea JG. Fish meal in animal feed and human exposure to persistent bioaccumulative and toxic substances. J Food Prot. 2006;69(11):2777–85.

^{‹‹125››.} Moser GA, McLachlan MS. The influence of dietary concentration on the absorption and excretion of persistent lipophilic organic pollutants in the human intestinal tract. Chemosphere. 2001;45(2):201–11.

^{‹‹126››.} D?rea JG. Vegetarian diets and exposure to organochlorine pollutants, lead, and mercury. Am J Clin Nutr. 2004;80(1):237–8.

^{‹‹127››.} Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol. 2012;72(6):893–901.

^{‹‹128››.} Barranco Quintana JL, Allam MF, Del Castillo AS, Navajas RF. Parkinson’s disease and tea: a quantitative review. J Am Coll Nutr. 2009;28(1):1–6.

^{‹‹129››.} Palacios N, Gao X, McCullough ML, et al. Caffeine and risk of Parkinson’s disease in a large cohort of men and women. Mov Disord. 2012;27(10):1276–82.

^{‹‹130››.} Nakaso K, Ito S, Nakashima K. Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson’s disease model of SH-SY5Y cells. Neurosci Lett. 2008;432(2):146–50.

^{‹‹131››.} Postuma RB, Lang AE, Munhoz RP, et al. Caffeine for treatment of Parkinson disease: a randomized controlled trial. Neurology. 2012;79(7):651–8.

^{‹‹132››.} Postuma RB, Lang AE, Munhoz RP, et al. Caffeine for treatment of Parkinson disease: a randomized controlled trial. Neurology. 2012;79(7):651–8.

^{‹‹133››.} Grazina R, Massano J. Physical exercise and Parkinson’s disease: influence on symptoms, disease course and prevention. Rev Neurosci. 2013;24(2):139–52.

^{‹‹134››.} Chen J, Guan Z, Wang L, Song G, Ma B, Wang Y. Meta-analysis: overweight, obesity, and Parkinson’s disease. Int J Endocrinol. 2014;2014:203930.